The metabolite N-4-methoxyphenylretinamide is a major determinant of fenretinide induced decline of plasma insulin-like growth factor-1
- 31 December 1995
- journal article
- other
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (3) , 420-421
- https://doi.org/10.1016/0959-8049(94)00524-9
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Five-year administration of fenretinide: pharmacokinetics and effects on plasma retinol concentrations.Journal of Clinical Oncology, 1993
- Distribution of fenretinide in the mammary gland of breast cancer patientsEuropean Journal of Cancer and Clinical Oncology, 1991
- Analysis of Insulin-Like Growth Factor I Gene Expression in Malignancy: Evidence for a Paracrine Role in Human Breast CancerMolecular Endocrinology, 1989